Presentation is loading. Please wait.

Presentation is loading. Please wait.

Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD.

Similar presentations


Presentation on theme: "Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD."— Presentation transcript:

1 Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD and Marc Passman, MD

2

3

4 Low risk: 0-1 Moderate risk: 2 High risk: 3-4 Very high risk: >5 All are significant when compared with normal BMI

5

6 P<0.05 for all overweight categories compared with NW

7

8

9 Mean VTE scores increase with increasing BMI Venous quality of life decreases with increasing BMI VCSS and CEAP scoring increases with increasing BMI Obesity contributes to CVD in the absence of moderate to severe valvular insufficiency


Download ppt "Colleen J. Moore, MD; Robert B. McLafferty, MD; Michele Lentz; Joseph R. Schneider, MD; Armen Roupenian, MD; Jennifer Heller, MD; W. Todd Bohannon, MD."

Similar presentations


Ads by Google